PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10339175

Cycle counting: a quality assurance process.

R A Stahl
View original source ↗Export metadata ↓

Abstract

Accurate inventory records result from careful tracking of in and out transactions. Regardless of how these transactions are done--by computer (backflush) or manually--they must be done correctly if accurate inventory records are to be the result. Cycle counting plays an important role in assuring that there is a sufficient inventory-tracking process in place to achieve accuracy. The purpose of this article is to explain how to use cycle counting to establish an effective process for keeping records accurate and how to ensure that it remains in place.

Explore related subjects

Effect Modifier, EpidemiologicEfficiency, OrganizationalIndustryInventories, HospitalOrganizational ObjectivesTotal Quality ManagementUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R A Stahl. 1998. Cycle counting: a quality assurance process.. https://pubmed.ncbi.nlm.nih.gov/10339175/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls.

INTRODUCTION: It is important yet difficult to maintain currency in clinical oncology practice. The emergence of new diagnostic technologies and new paradigms for cancer treatment combine to produce a rapidly changing clinical approach to patients aided by the increasing use of multidisciplinary care teams and development of evidence-based protocols. METHODS: Teams of experts review the literature in a given area and produce management guidelines and protocols for use by practicing clinicians. Traditionally within Hematology/Oncology, these guidelines have been directed to management of a given tumor type. However, in recent years, attention has increasingly turned to supportive oncology; for example, there are now management guidelines for conditions such as neutropenic fever [Hughes et al. Clinical Infectious Diseases 34(6):730-751, 2002], antiemetic (The Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer Annals of Oncology 17:20-28, 2006) and most recently, mucositis [Rubenstein et al. Cancer 100(9 Suppl):2026-2046, 2004]. It is critical that any guideline process should include education, evaluation, and timely update in its remit, because guidelines become highly compromised if their existence is not widely known, if they do not facilitate clinical practice, or if they are not reflective of contemporary medical literature. RESULTS: The Mucositis Study Group (MSG) of the Multinational Association for Supportive Care in Cancer/International Society for Oral Oncology was created in 1998 to specifically address the multiprofessional approach to clinical care, research, and education associated with mucosal injury in cancer patients. A specific outcome has been the development of evidence-based guidelines for the management of mucositis [Rubenstein et al. Cancer 100(9 Suppl):2026-2046, 2004; The Mucositis Study Group of MASCC/ISSO 2005]. The original guidelines [Rubenstein et al. Cancer 100(9 Suppl):2026-2046, 2004] and a companion paper discussing the science behind mucositis [Sonis et al. Cancer 100(9):1995-2025, 2004], were published in 2004. The MSG has recently updated the guidelines [The Mucositis Study Group of MASCC/ISSO 2005]. DISCUSSION: This paper discusses the process involved and the lessons learned that might help other groups planning to undertake a similar project.

Effect Modifier, Epidemiologic↗